Health effects in army gulf war veterans possibly exposed to chemical munitions destruction at Khamisiyah, Iraq: Part I. Morbidity associated with potential exposure

Military Medicine

Volumn 170, Issue 11, 2005, Pages 935-944

  Mahan, Clare M ^a   Page, William F ^b   Bullman, Tim A ^a   Kang, Han K ^a  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b INSTITUTE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMICAL WARFARE AGENT; CYCLOSARIN; SARIN; UNCLASSIFIED DRUG;

ADULT; ARMY; ARTICLE; CHEMICAL WARFARE; CLINICAL FEATURE; CONTROLLED STUDY; DEMOGRAPHY; EVALUATION; FEMALE; HEALTH HAZARD; HEALTH STATUS; HEALTH SURVEY; HUMAN; IRAQ; MAJOR CLINICAL STUDY; MALE; MORBIDITY; OCCUPATIONAL EXPOSURE; SOLDIER; SYMPTOMATOLOGY; UNITED STATES;

EID: 27744438933     PISSN: 00264075     EISSN: None     Source Type: Journal    
DOI: 10.7205/MILMED.170.11.935     Document Type: Article

References (23)

1. Office of the Special Assistant for Gulf War Illnesses: Case narrative: U.S. Demolition Operations at Khamisiyah, April 16, 2002. Available at http://www.gulflink.osd.mil/khamisiyah_iii/.
2. Kang HK, Mahan CM, Lee KY, Magee CA, Murphy FM: Illnesses among United States veterans of the Gulf War: a population-based survey of 30,000 veterans. J Occup Environ Med 2000; 42: 491-501.
3. Bullman TA, Mahan CM, Kang HK, Page WF: Mortality in U.S. Army Gulf War veterans exposed to 1991 Khamisiyah chemical munitions destruction. Am J Public Health 2005; 95: 1382-8.
4. Page WF, Mahan CM, Kang HK, Bullman TA: Health effects in Army Gulf War veterans possibly exposed to chemical munitions destruction at Khamisiyah, Iraq: II: Morbidity associated with notification of potential exposure. Milit Med 2005; 170: 000-000.
5. Centers for Disease Control and Prevention: Unexplained illness among Persian Gulf War veterans in an Air National Guard unit: preliminary report: August 1990-March 1995. MMWR 1995; 44: 443-7.
6. Nicholson GL, Hyman E, Korenyi-Both A, et al: Progress on Persian Gulf War illnesses: reality and hypotheses. Int J Occup Med Toxicol 1995; 4: 365-70.
7. Persian Gulf Veterans Coordinating Board: Unexplained illnesses among Desert Storm veterans: a search for causes, treatment, and cooperation. Arch Intern Med 1995; 155: 262-8.
8. Presidential Advisory Committee on Gulf War Veterans' Illnesses: Interim Report. Washington, DC, U.S. Government Printing Office, 1996.
9. Presidential Advisory Committee on Gulf War Veterans' Illnesses: Final Report. Washington, DC, U.S. Government Printing Office, 1996.
10. Gray GC, Smith TC, Knoke JD, Heller JM: The postwar hospitalization experience of Gulf War veterans possibly exposed to chemical munitions destruction at Khamisiyah, Iraq. Am J Epidemiol 2000; 150: 532-40.
11. McCauley LA, Rischitelli G, Lambert WE, Lasarev M, Sticker DL, Spencer PS: Symptoms of Gulf War veterans possibly exposed to organophosphate chemical warfare agents at Khamisiyah, Iraq. Int J Occup Environ Health 2001; 7: 79-89.
12. McCauley LA, Joos SK, Spencer PS, et al: Strategies to assess validity of self reported exposures during the Persian Gulf War. Environ Res 1999; 81: 195-205.
13. Office of the Special Assistant for Gulf War Illnesses: Case narrative: U.S. Demolition Operations at Khamisiyah, April 16, 2002: section III. narrative H: Department of Defense announced possible chemical weapons at Khamisiyah: January-September 1996. Available at http://www.gulflink.osd.mil/khamisiyah_iii/ khamisiyah_iii_s05.htm.
14. National Research Council, Board on Environmental Studies and Toxicology, Committee on Toxicology, Subcommittee on Acute Exposure Guideline Levels: Acute Exposure Guideline Levels for Selected Airborne Chemicals, Vol 3, pp 15-18. Washington, DC, National Academy Press, 2003.
15. Institute of Medicine, Division of Health Promotion and Disease Prevention. Committee on Health Effects Associated with Exposures during the Gulf War: Gulf War and Health, Vol 1, Depleted Uranium. Pyridostigmine Bromide, Sarin, Vaccines. Washington, DC, Institute of Medicine, National Academy Press. 2000.
16. Page WF: Long-term health effects of exposure to sarin and other anticholinesterase chemical warfare agents. Milit Med 2003; 168: 239-45.
17. Blanchard EB, Jones-Alexander J, Buckley TC, Forneris CA: Psychometric properties of the PTSD Checklist (PCL). Behav Res Ther 1996; 34: 669-73.
18. Weathers FW, Lite BT, Herman DS, Huska JA, Keane TM: The PTSD Checklist (PCL): reliability, validity, and diagnostic utility. Presented at the Ninth Annual Meeting of the International Society for Traumatic Stress Studies, October 24-27, 1993, San Antonio, TX.
19. Fukuda K, Straus SE, Hickie I, Sharpe MC, Dobbins JG, Komaroff A: International Chronic Fatigue Syndrome Study Group: the chronic fatigue syndrome: a comprehensive approach and its definition and study. Ann Intern Med 1994; 121: 953-9.
20. Kang HK, Natelson BH, Mahan CM, Lee KY, Murphy FM: Post-traumatic stress disorder and chronic fatigue syndrome-like illness among Gulf War veterans: a population based survey of 30,000 veterans. Am J Epidemiol 2003; 157: 141-8.
21. D'Agostino RB Jr: Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group. Stat Med 1998; 17: 2265-81.
22. SAS Institute: SAS Online Doc, Version 8. Cary, NC, SAS Institute, 1999.
23. Rhodes K: Gulf War Illnesses: Preliminary Assessment of Dodd Plume Modeling for U.S. Troops' Exposure to Chemical Agents. Report GAO-03-833T. Washington, DC, U.S. General Accounting Office, 2003.